title: Chipping of calcified plaques by orbital atherectomy systems, but holding approval tight: is the FDA moving faster than the European CE agency? A North American perspective.
authors.affiliation: MedStar Washington Hospital Center, Section of Interventional Cardiology, Washington DC, USA.
authors.forename: Ron
authors.initials: R
authors.lastname: Waksman
authors.forename: Hector M
authors.initials: HM
authors.lastname: Garcia-Garcia
mesh_terms: D017225:Atherectomy, Coronary / Q000295:instrumentation*; D018795:Device Approval; D005060:Europe; D006801:Humans; D058226:Plaque, Atherosclerotic / Q000601:surgery*; D014481:United States; D014486:United States Food and Drug Administration; D061205:Vascular Calcification / Q000601:surgery*